The evaluation will be published in the Wounds UK Journal, 2009, Vol 5, No 4. Undertaking an evaluation of a new product is an essential part of the decision-making process when considering implementing a new therapy or dressing. This project describes a process whereby clinicians undertook this in a structured manner providing them with data on outcomes and cost. It involved completing an evaluation form, in which an initial patient and wound assessment was undertaken, followed by recording the outcome of each dressing changed. This information was then collated and analysed, giving the evaluation site access to a structured report which they can use to support the decision-making process.
Negative Pressure Wound Therapy (NPWT) is now an accepted treatment in wound care, but historically its use may have been restricted to the most complex wounds because of the previously high unit cost of the traditional system. With lower price alternative systems becoming available, there is an opportunity to offer this therapy to more patients. However it is important that this treatment produces acceptable clinical outcomes in a range of wound types.To date there is no published research which compares the performance of one system with another. As a result clinicians often have to use the available non comparative evidence and the experience of their own evaluations, which may be limited in patient numbers, wound aetiology and care settings.
The process enabled the participating clinicians to generate objective data on their evaluations of the VENTURI®. It demonstrated the device to be highly acceptable to both patients and staff, and because of its ease of use and effectiveness can facilitate the appropriate use of nursing time. The evaluation of the VENTURI® also demonstrated that it can have a positive effect on wound healing, both in reducing wound size and the incidence of devitalised tissue in the wound bed. It can also make an impact on wound complications such as pain and infection. With the increasing burden of wound care and its associated costs, it is important that clinicians are provided with the opportunity to use new technologies in their own clinical practice. This project has enabled the participants to objectively collect information on a new NPWT device and consider the VENTURI® as a possible cost-effective alternative option in wound care.
To obtain a copy of the article contact furtherinfo@wounds-uk.com or visit www.wounds-uk.com For further information on the Venturi® NPWT device contact sales@talleygroup.com
For more information:
http://www.wounds-uk.com
Comments